等待开盘 02-05 09:30:00 美东时间
0.000
0.00%
再鼎医药宣布,奥凯乐(瑞普替尼)获中国NMPA批准治疗ROS1阳性非小细胞肺癌。FDA也已批准其用于相同适应证,并给予多项突破性治疗认定及快速通道资格。再鼎医药...
2024-05-13 15:27
Dr. Levy brings more than 25 years of biopharma industry experience, including ...
2023-07-20 20:00
随着美国通胀降温,部分机构开始看好2023年科技股表现;但有分析师“泼冷水”,阐述了2023年科技股将继续低迷的理由,去年其投资组合表现远超标普500;该分析师给出详细投资策略>>
2023-01-13 22:38
Turning Point Therapeutics (NASDAQ:TPTX – Get Rating) announced its quarterly e...
2022-08-09 20:52
Fisker业绩超预期却被分析师砍价,看跌单押注10美元;科技股EPAM业绩超预期,千张看涨大单瞄准480美元目标价;AMC院线、3B家居获散户推崇,成交量挤上TOP10榜单>>
2022-08-08 22:45
Bristol Myers Squibb (NYSE:BMY) today has announced that Rhumba Merger Sub Inc. ("Offeror"), a wholly owned subsidiary of Bristol Myers Squibb, has extended the expiration date of its offer (the
2022-07-19 18:59
Shares of Turning Point Therapeutics, Inc. (NASDAQ:TPTX – Get Rating) have been...
2022-07-11 15:21